A4 Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 01-11-2024
- Paid Up Capital ₹ 3.70 M
as on 01-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.68 Cr
as on 01-11-2024
- Revenue 4.33%
(FY 2023)
- Profit 149.53%
(FY 2023)
- Ebitda 13.88%
(FY 2023)
- Net Worth 14.61%
(FY 2023)
- Total Assets 2.27%
(FY 2023)
About A4 Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 3.70 M.
The company currently has active open charges totaling ₹1.68 Cr.
Karpagameena, Rajagopalan Anbalagan, and Thenmozhi serve as directors at the Company.
- CIN/LLPIN
U85110TN2020PTC138530
- Company No.
138530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at A4 Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karpagameena  | Director | 09-Oct-2020 | Current |
| Rajagopalan Anbalagan | Director | 09-Oct-2020 | Current |
| Thenmozhi | Director | 15-Sep-2021 | Current |
Financial Performance of A4 Diagnostics.
A4 Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.33% increase. The company also saw a substantial improvement in profitability, with a 149.53% increase in profit. The company's net worth Soared by an impressive increase of 14.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A4 Diagnostics?
Unlock access to A4 Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kenzo Ortho And Women Care Centre Private LimitedActive 4 years 2 monthsKarpagameena, Rajagopalan Anbalagan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Sep 2024 | ₹9.44 M | Open |
State Bank Of India Creation Date: 09 Apr 2021 | ₹7.40 M | Open |
How Many Employees Work at A4 Diagnostics?
A4 Diagnostics has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A4 Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A4 Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
